HNSCC-derived EVs carrying natural killer receptor G2 (NKG2D) ligands contribute to evading immunity by deceptively weakening the cytotoxicity of NKG2D-mediated NK cells [118–121]. Here, KLRK1 is linked to head and neck squamous cell carcinoma.